SARS-CoV-2 Antigen Rapid Qualitative Test Type B

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

BNP Rapid Quantitative Test

During heart failure, the heart makes two proteins, called B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NT-proBNP). Levels of both in the blood go up when heart failure gets worse and go down when it gets better.

Dengue NS1 Antigen Rapid Test

The Dengue NS1 Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Dengue virus NS1 antigen in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with the dengue virus. For professional in vitro diagnostic use only.

PCT Rapid Quantitative Test

PCT(Procalcitonin) is a peptide precursor of the hormone calcitonin. Measurement of PCT can be used as an authoritative marker for diagnosis and stratification of sepsis.

RSV Antigen Rapid Test

The RSV antigen rapid test is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute RSV virus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.

HCV Rapid Quantitative Test

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV): the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is a major cause of liver cancer.

hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)

hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac troponin I (hs-cTnI) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B